News Archives - Page 677 of 742

FridayOct 26, 2018 10:06 am

CytoDyn Inc. (CYDY) to Complete Development of Prostate Cancer Prognostic Test Following Close of ProstaGene Acquisition

PCaTest has already proven a superior predictive ability in comparison with other genetic prognostic tests Cytodyn in the process of acquiring PCaTest developer ProstaGene and will launch a clinical study once the transaction is complete Prostate cancer is the second-most common type of cancer among American men, with almost 165,000 new cases expected this year Biotechnology company CytoDyn Inc. (OTCQB: CYDY) has unveiled a comprehensive strategy for the development of a genetic prostate cancer prognostic test (http://ibn.fm/GSEfb). Developed by ProstaGene, an entity that CytoDyn is in the process of acquiring, PCaTest has already demonstrated superior predictive ability in comparison to other…

ThursdayOct 25, 2018 11:59 am

CytoDyn Inc. (CYDY) Finding Success in Trials of PRO 140 for Treatment of HIV/AIDS; Plans to Expand Clinical Investigations to Cancer

Lead product candidate, PRO 140, is a viral-entry inhibitor that works by blocking the entry of HIV/AIDS to healthy cells by masking CCR5 receptor Completion of Biological License Application (BLA) for potential approval in combination HIV therapy expected in Q1 2019 CytoDyn received approval to increase dosing of PRO 140 in its phase 3 adaptive clinical trial for enrolled HIV/AIDS patients Market potential for PRO 140 as an anti-viral agent in combination with HAART is $1.2 billion; as a monotherapy maintenance/single-drug therapy, the market is estimated at $3.8 billion Acquisition of privately held ProstaGene expected to complete in November, giving…

ThursdayOct 25, 2018 11:41 am

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF) Encounters Lithium Brines in Additional Drill Holes, Confirming Geophysical Profile of Ollague Project

Drilling shows additional lithium-bearing brines carrying highly conductive zones, suggesting that lithium grades increase with depth Brines tested lithium grades starting at 150 mg/l, increasing to 270 mg/l when drill holes reached 250-meter contracted depth Results of recent drilling reinforce company’s decision to test deeper limits of aquifer Lithium Chile holds one of the largest lithium land holdings in Chile, a country with about 50 percent of the world’s reserves Global demand for lithium, which is vital to rechargeable batteries, is expected to increase by 650 percent by 2027 Mineral explorer Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF) continues to…

ThursdayOct 25, 2018 11:07 am

Cannabis Strategic Ventures, Inc. (NUGS) Welcomes PureOrganix Shelf Presence as Sign of Life in Growing Industry

Americans spending a growing amount of capital on cannabis concentrates, with forecasts for $2.9 billion in sales this year Cannabis Strategic Ventures recently announced the introduction of high-quality concentrate line PureOrganix in California dispensaries PureOrganix presence expected to gain national, international footing amid advancing tide of cannabis legalization Cannabis industry incubator Cannabis Strategic Ventures, Inc. (OTC: NUGS) is working its way toward a national stock exchange uplisting and growing its presence within the industry through a series of timely business building ventures, including the introduction of PureOrganix, a brand marketed by subsidiary Pure Applied Sciences as a California dispensary shelf…

ThursdayOct 25, 2018 10:45 am

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Advances Breast Cancer Therapy Trials to Patient Dosing Stage

Breast cancer is the leading cancer diagnosed in women and the second-most common cancer overall BriaCell Therapeutics has begun patient dosing in clinical trials that combine its trademarked Bria-IMT technology with celebrated cancer-fighting antibodies The clinical trials are working on a therapy that will help the body’s own immune system fight cancerous cells The battle against breast cancer is taking a technological turn amid an increasing drive to develop therapies that use the body’s own immune system to destroy life-threatening cancer cells. BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) is on the front line of the battle and is currently…

WednesdayOct 24, 2018 11:33 am

Net Element, Inc. (NASDAQ: NETE) Launches Fully Compliant Cannabis Industry Payment Solution, Company Stock Skyrockets

Net Element stock skyrocketed after the company announced the launch of a fully compliant payment solution for the legal cannabis industry Shares grew 63 percent, with volume eventually increasing to 9.5 million shares from previous full-day averages of 81,000 shares The payment solution enables entry into a lucrative field that’s forecast to grow beyond $22 billion by 2022 On October 22, global technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) announced the launch of a fully-compliant payment solution for the legal cannabis industry. The payment processing solution is designed to provide a smooth transaction between merchants and consumers…

WednesdayOct 24, 2018 11:13 am

DeepMarkit Corp. (TSX.V: MKT) (OTC: MKTDF) Launches Premium Toolkit for E-Commerce Merchants on Shopify, WordPress, BigCommerce and Weebly

New premium toolkit, which can also be installed on any website, is designed to drive website traffic, then convert visitors into customers for merchants Carter Chalmers, MKTDF director of sales and business development, says that the company’s new features include draw prize sweepstakes and 12 premium games for social media campaigns MKTDF’s gamification strategy uses surveys and games to turn unknown social media followers into identified email subscribers/paying customers and drive them to websites DeepMarkit Corp. (TSX.V: MKT) (OTCQB: MKTDF) is taking its gamification marketing strategy to a higher level by introducing a premium toolkit laden with new features, such…

WednesdayOct 24, 2018 10:55 am

ChineseInvestors.com, Inc. (CIIX) Enters Agreement with Tmall, Reports Impressive Financial Numbers

ChineseInvestors.com reports a total year-over-year revenue increase of 70 percent for the first fiscal quarter of 2019 The company’s current assets have nearly doubled, and its share price touched $0.90 per share as of October 17, 2018 The agreement entered between CBD Biotechnology Co. Ltd. and Tmall is likely to boost industrial hemp CBD sales With products on Tmall, CBD Biotechnology Co. Ltd is positioned to cash in on Double 11 and Double 12 shopping festivals ChineseInvestors.com, Inc. (OTCQB: CIIX) recorded impressive first quarter financial results for its fiscal year 2019. Its total revenue, comprising product sales revenue and subscription…

WednesdayOct 24, 2018 10:36 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Receives Two US Patents, Bringing Total to 10 in First Patent Family across US and Australia

The two new patents are related to certain cannabinoid-infused beverage compositions using LXRP’s DehydraTECH technology Globally, LXRP has filed some 50 patent applications as the company expands its IP portfolio; LXRP hopes to receive two more granted patents from Australia by year end, giving it 12 in total LXRP out-licenses its technology, which promotes healthier and faster ingestion; the company seeks accelerated patent application examinations in Australia based on the U.S. patents Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has been granted two new U.S. patents based on cannabinoid-infused beverage compositions using its DehydraTECH ingestion technology platform. The company is…

Site Search

Company Search

Category: News